Contract award · 16 Mar 2026

NHSE1051 Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) for the North West of England

NHS England North West awarded “Autologous Chrondrocyte Implantation (ACI) and Osteochondral…” to Manchester University Foundation Trust for £1.65m.

No competitionHealth & social careNorth West

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Buyer
NHS England North West · Body governed by public law
Value
£1,650,000
Procedure
Award procedure without prior publication of a call for competition
Sector
Health & social care · Health services (CPV 85100000)
Timeline
  1. Contract date16 Mar 2026
  2. Published16 Mar 2026Published the same day

Description

Autologous Chrondrocyte Implantation (ACI) and Osteochondral Allograft (OCA) This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The Relevant Authority is intending to award a contract to the existing provider following Direct Award Process C. The publication of this notice marks the start of the Standstill Period. Representations by providers must be made to decision makers by 27 March 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. The contract will commence on 01 April 2026 and conclude on 31 March 2029.

About the supplier

More from NHS England North West

All contracts

More won by Manchester University Foundation Trust

All contracts

Recent health & social care contracts

Sector overview